Perspectives for immunotherapy in glioblastoma treatment
/in Dendritic Cells, Glioblastoma, International Publications /von 2014-11-01 / Curr Opin Oncol 2014 Nov;26(6):608-14Antigen targeting to dendritic cells combined with transient regulatory T cell inhibition results in long-term tumor regression
/in Dendritic Cells, International Publications /von 2014-10-31 / Oncoimmunology 2015 Aug;4(8):e970462Dendritic cell cancer vaccines: from the bench to the bedside
/in Dendritic Cells, International Publications /von 2014-10-29 / Rambam Maimonides Med J 2014 Oct;5(4):e0024Enhancing dendritic cell-based vaccination for highly aggressive glioblastoma
/in Dendritic Cells, Glioblastoma, International Publications /von 2014-10-18 / Expert Opin Biol Ther 2015 Jan;15(1):79-94Long-term remission of prostate cancer with extensive bone metastases upon immuno- and virotherapy: A case report
/in Dendritic Cells, Hyperthermia, International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus, Prostate Cancer /von 2014-10-06 / Oncol Lett 2014 Dec;8(6):2403-2406Randomized controlled phase III trial of adjuvant chemo-immunotherapy with activated killer T cells and dendritic cells in patients with resected primary lung cancer
/in Dendritic Cells, International Publications, NSCLC /von 2014-09-28 / Cancer Immunol. Immunother. 2015 Jan;64(1):51-9Radiotherapy as an immunological booster in patients with metastatic melanoma or renal cell carcinoma treated with high-dose Interleukin-2: evaluation of biomarkers of immunologic and therapeutic response
/in Dendritic Cells, Hypernephroma, International Publications, Malignant Melanoma /von 2014-09-23 / J Transl Med 2014 Sep;12:262Antigen-loaded dendritic cell migration: MR imaging in a pancreatic carcinoma model
/in Dendritic Cells, International Publications, Pancreatic Cancer /von 2014-09-15 / Radiology 2015 Jan;274(1):192-200Clinical efficacy of tumor antigen-pulsed DC treatment for high-grade glioma patients: evidence from a meta-analysis
/in Dendritic Cells, Glioblastoma, International Publications /von 2014-09-12 / PLoS ONE 2014;9(9):e107173
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de